Cite

    Patel, A., Szydlo, R. M., Auner, H. W., Kanfer, E. J., MacDonald, D. H., Milojkovic, D., Altaf, S., Innes, A., Gabriel, I., Rahemtulla, A., Chaidos, A., Karadimitris, A., Olavarria, E., Apperley, J. F., & Pavlů, J. (2018). c‐reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early‐ and long‐term mortality. British journal of haematology, 180, 889–892. http://access.bl.uk/ark:/81055/vdc_100057849076.0x00005b